跳至主要内容
临床试验/NCT07088302
NCT07088302招募中不适用

Effect OF Lactase Enzyme Supplements ON Protection Against Feeding Intolerance IN Preterm Neonates

Alexandria University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年8月30日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Feeding intolerance:

研究概览

简要总结

This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Days 至 1 Month(Child)
性别
All
接受健康志愿者

入选标准

  • will be as follows:
  • Preterm neonates ≤ 32 weeks gestational age.
  • Start feeding in the first 72 hours of life. 8.

排除标准

  • Patients with any of the following will be excluded:
  • Parental consent lacking/refusal.
  • Obvious major congenital abnormalities.
  • Infants more than 72 hours of age at the time of randomization.
  • Delayed introduction of feeding (beyond three days of life).
  • Known galactosemia.
  • Severe IUGR. -

研究组 & 干预措施

Lactase enzyme group

Active Comparator

干预措施: lactase administration (Drug)

Control group

Placebo Comparator

干预措施: placebo (Other)

结局指标

主要结局

Feeding intolerance:

时间窗: first two weeks of life

vomiting number per day aspirates in ml/day abdominal distension by measuring abdominal circumference before and after feeds

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Mohamed Farag

Assistant professor of Pediatrics

Alexandria University

研究点 (1)

Loading locations...

相似试验